Business, energy, technology, markets and global industry news from Business News Today

Abbott Laboratories

PharmaDeviceNews Abbott Laboratories
Representative image: A continuous glucose monitoring sensor and smartphone glucose trend display illustrate how Dexcom G7 could expand CGM use for adults with type 2 diabetes not using insulin after the CONNECT study.
Medical Devices & Diagnostics

Can Dexcom G7 reshape CGM adoption for type 2 diabetes patients not using insulin?

Find out how Dexcom G7 data could reshape CGM adoption for type 2 diabetes patients not using insulin.

Read More
Medical Devices & Diagnostics

Is Abbott building the next integrated platform for complex heart rhythm treatment?

Abbott has PFA momentum, but rhythm care is becoming a platform battle. Can clinical data turn into durable adoption?

Read More